Back to Search Start Over

Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis.

Authors :
Chen C
Xie B
Li Z
Chen L
Chen Y
Zhou J
Ju S
Zhou Y
Zhang X
Zhuo W
Yang J
Mao M
Xu L
Wang L
Source :
Cell death & disease [Cell Death Dis] 2022 Feb 14; Vol. 13 (2), pp. 150. Date of Electronic Publication: 2022 Feb 14.
Publication Year :
2022

Abstract

Ferroptosis, which is characterized by intracellular iron accumulation and lipid peroxidation, is a newly described form of regulated cell death that may play a key role in tumour suppression. In the present study, we investigated the expression profiles and biological effects of fascin actin-bundling protein 1 (Fascin, gene name FSCN1) in breast cancer. In addition, bioinformatics analysis of the TCGA cancer database and gain- and loss-of-function studies showed that Fascin enhances sensitivity to erastin-induced ferroptosis. Mechanistically, Fascin directly interacts with cysteine/glutamate transporter (xCT, gene name SLC7A11) and decreases its stability via the ubiquitin-mediated proteasome degradation pathway. Furthermore, we observed that Fascin is substantially upregulated in tamoxifen-resistant breast cancer cell lines, and drug-resistant cells were also more vulnerable to erastin-induced ferroptosis. Taken together, our findings reveal a previously unidentified role of Fascin in ferroptosis by regulating xCT. Thus, ferroptosis activation in breast cancer with high Fascin level may serve as a potential treatment.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2041-4889
Volume :
13
Issue :
2
Database :
MEDLINE
Journal :
Cell death & disease
Publication Type :
Academic Journal
Accession number :
35165254
Full Text :
https://doi.org/10.1038/s41419-022-04579-1